Global Sequencing Kits Market, By Type (Sanger Sequencing, Next Generation Sequencing, Third Generation Sequencing), Application (Oncology, Retypeive Health, Clinical Investigation, Agrigenomics and Forensics, Other) End Use (Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Academic and Research Institutes Others) – Industry Trends and Forecast to 2029.
Sequencing Kits Market Analysis and Size
The technique of figuring out the nucleotide sequence of a given DNA fragment is called DNA sequencing. The chain termination technique invented by Frederick Sanger has been used for the majority of DNA sequencing procedures up to this point. This method employs sequence-specific termination of a DNA synthesis reaction using modified nucleotide substrates. New sequencing techniques, such pyrosequencing, are, nonetheless, capturing a larger portion of the sequencing business. Pyrosequencing is currently producing more genomic data than Sanger DNA sequencing. Genome sequencing has been made possible via pyrosequencing. This method allows bacterial genomes to be sequenced in a single run with multiple times coverage. James Watson's genome was recently sequenced using this method as well.
Data Bridge Market Research analyses that the sequencing kits market which was USD 5258.07 million in 2021, would rocket up to USD 12426.48 million by 2029, and is expected to undergo a CAGR of 11.35% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Sequencing Kits Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Sanger Sequencing, Next Generation Sequencing, Third Generation Sequencing), Application (Oncology, Retypeive Health, Clinical Investigation, Agrigenomics and Forensics, Other) End Use (Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Academic and Research Institutes Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Illumina, Inc. (U.S.), Roche Sequencing (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Agilent Technologies, Inc. (U.S.), Oxford Nanopore Technologies Plc (U.K.), Thermo Fisher Scientific Inc. (U.S.), QIAGEN (Germany), BGI Group (China), PacBio (U.S.), Fluidigm (U.S.), ArcherDX, Inc. (U.S.), Takara Bio Inc. (Japan), Bioline (Canada), PerkinElmer Inc. (U.S.)
|
|
Market Opportunities
|
|
Market Definition
An unbranched biopolymer's primary structure, sometimes wrongly referred to as the primary sequence, is determined through sequencing. The outcome of sequencing is a symbolic linear representation known as a sequence, which neatly condenses most of the sequenced molecule's atomic-level structure.
Sequencing Kits Market Dynamics
Drivers
- Research and development activities
The terminology like DNA, RNA, and genome or genetic is vital to developing the advanced healthcare sector in the biotech sector. Sequencing kits support continuing research and advancements for the investigations of reagents. Demand is growing the market at a rapid rate.
- Advancements in Sequencing kits
Certain changes have made buying and distributing sequencing kits more commercially viable, which is much more affordable than previously. This coefficient has sparked a global market expansion, which has boosted the industry's growth. Due to the promotion of an advanced supply chain, possible market leaders have created a pertinent level of competition, which is proving to be highly beneficial for the market for sequencing kits over the forecast period of 2022 to 2029.
- Rise in the geriatric population
The rising prevalence rates of lifestyle disorders like as diabetes and obesity, rising health-care spending, and the fast-growing diagnostic industry are driving the worldwide sequencing kits market expansion. In addition, the growing elderly population, increased demand for laboratory automation, and more awareness of preventative healthcare are all driving the sequencing kits market forward.
Opportunities
- Increase in the number of research and development activities
The industry is expanding enormously thanks to the generous investments and financial resources made available for R&D activity at public and private institutions and research labs.
Restraints/Challenges
Sequencing kit industry is exposed to some market-crushing factors during the anticipated seven-year market emergence period, such as experiments on rodents and animals that violate ethical standards, which can restrain the market's growth.
This sequencing kits market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the sequencing kits market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Sequencing Kits Market
The COVID-19 pandemic had a favourable effect on the market under investigation since it enhanced demand for sequencing kits in the field of developing treatments and diagnostics. Therefore, the market is expected to maintain its high growth rate over the forecast period due to the growing sequencing-based research and development activities in the development of diagnostic tools or efficient therapies for COVID-19.
Recent Development
- In August 2021, Asuragen and Pacific Biosciences joined forces to enhance tests for carrier screening and other applications based on AmplideX PCR Chemistry and SMRT Sequencing Technology.
Global Sequencing Kits Market Scope
The sequencing kits market is segmented on the basis of type, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Sanger Sequencing
- Next Generation Sequencing
- Third Generation Sequencing
Application
- Oncology
- Retypeive Health
- Clinical Investigation
- Agrigenomics and Forensics
- Other
End Use
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Others
Sequencing Kits Market Regional Analysis/Insights
The sequencing kits market is analysed and market size insights and trends are provided by country, type, application and end-user as referenced above.
The countries covered in the sequencing kits market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the sequencing kits market due to the eminent players and better genetic science infrastructure.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the focus of various established market players to expand their presence in this particular region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Sequencing Kits Market Share Analysis
The sequencing kits market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to sequencing kits market.
Some of the major players operating in the sequencing kits market are:
- Illumina, Inc. (U.S.)
- Roche Sequencing (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Agilent Technologies, Inc. (U.S.)
- Oxford Nanopore Technologies Plc (U.K.)
- Thermo Fisher Scientific Inc. (U.S.)
- QIAGEN (Germany)
- BGI Group (China)
- PacBio (U.S.)
- Fluidigm (U.S.)
- ArcherDX, Inc. (U.S.)
- Takara Bio Inc. (Japan)
- Bioline (Canada)
- PerkinElmer Inc. (U.S.)
SKU-